Piramal Enterprises has received an approval for scheme of amalgamation for merger of the step-down wholly-owned subsidiaries - PHL Capital, Piramal Pharmaceutical Development Services and Oxygen Bio Research, with itself. The board of directors at its meeting held on May 05, 2014 has approved for the same.
Further, as mentioned above, since all the transferor companies are step down wholly owned subsidiaries of the company, no shares are proposed to be issued pursuant to the merger. This scheme is subject to requisite approvals, including under the Listing Agreement and by the High Courts.
Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and healthcare information management sectors.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 921.45 |
| Shriram Finance | 1010.75 |
| Aditya Birla Capital | 340.15 |
| Chola Invest & Fin. | 1568.70 |
| Tata Capital | 337.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: